» Articles » PMID: 20230372

Lipophilic Mediated Assays for Beta-hematin Inhibitors

Overview
Specialty Chemistry
Date 2010 Mar 17
PMID 20230372
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

The growing drug resistance of Plasmodia spp. to current antimalarial agents in the quinine and artemisinin families further asserts the need for novel drug classes to combat malaria infection. One approach to the discovery of new antimalarials is the screening of natural product extracts for activity against the formation of hemozoin, a biomineral essential to parasite survival. By mimicking the in vivo lipid-water interface at which native hemozoin is found, hemozoin can be synthesized outside the parasite. In this work, a variety of lipophilic mediators was used to determine the optimal platform for in vitro hemozoin formation and then tested for efficacy in preliminary screens containing crude natural product extracts. The complete optimization and validation of a NP-40 detergent-mediated assay provide a screening template with an expedited 4-hour incubation time and identical IC50 values to those measured from the parasite's native lipid component.

Citing Articles

Quinoxaline-based anti-schistosomal compounds have potent anti-plasmodial activity.

Rawat M, Padalino G, Adika E, Okombo J, Yeo T, Brancale A PLoS Pathog. 2025; 21(2):e1012216.

PMID: 39899599 PMC: 11809919. DOI: 10.1371/journal.ppat.1012216.


Development and experimental validation of a machine learning model for the prediction of new antimalarials.

Kore M, Acharya D, Sharma L, Vembar S, Sundriyal S BMC Chem. 2025; 19(1):28.

PMID: 39885590 PMC: 11783816. DOI: 10.1186/s13065-025-01395-4.


antiplasmodium and antitrypanosomal activities, β-haematin formation inhibition, molecular docking and DFT computational studies of quinoline-urea-benzothiazole hybrids.

Oyeneyin O, Moodley R, Mashaba C, Garnie L, Omoboyowa D, Rakodi G Heliyon. 2024; 10(19):e38434.

PMID: 39397937 PMC: 11471183. DOI: 10.1016/j.heliyon.2024.e38434.


Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II genetic cross.

Kanai M, Mok S, Yeo T, Shears M, Ross L, Jeon J bioRxiv. 2024; .

PMID: 39386571 PMC: 11463348. DOI: 10.1101/2024.09.27.615529.


Identifying inhibitors of β-haematin formation with activity against chloroquine-resistant Plasmodium falciparum malaria parasites via virtual screening approaches.

Amod L, Mohunlal R, Teixeira N, Egan T, Wicht K Sci Rep. 2023; 13(1):2648.

PMID: 36788274 PMC: 9929333. DOI: 10.1038/s41598-023-29273-w.


References
1.
Pagola S, Stephens P, Bohle D, Kosar A, Madsen S . The structure of malaria pigment beta-haematin. Nature. 2000; 404(6775):307-10. DOI: 10.1038/35005132. View

2.
White N . Qinghaosu (artemisinin): the price of success. Science. 2008; 320(5874):330-4. DOI: 10.1126/science.1155165. View

3.
Parapini S, Basilico N, Pasini E, EGAN T, Olliaro P, Taramelli D . Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Exp Parasitol. 2001; 96(4):249-56. DOI: 10.1006/expr.2000.4583. View

4.
Ziegler J, Linck R, Wright D . Heme Aggregation inhibitors: antimalarial drugs targeting an essential biomineralization process. Curr Med Chem. 2001; 8(2):171-89. DOI: 10.2174/0929867013373840. View

5.
Ziegler J, Pasierb L, Cole K, Wright D . Metalloporphyrin probes for antimalarial drug action. J Inorg Biochem. 2003; 96(4):478-86. DOI: 10.1016/s0162-0134(03)00253-8. View